Evidence map›Paper›PMID 28477669›Full record

ReviewClinics in perinatology2017

The Microbiota of the Extremely Preterm Infant.

Mark A Underwood, Kristin Sohn

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Clinics in perinatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 62 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05427760 nacompletednot on this mapstarted 2022, after this paper: background citation

Effect of Using Oxygen on the Diaper Dermatitis in Infants

TypeinterventionalSponsorIstanbul University - CerrahpasaRan2022 to 2023Enrolled103ConditionsDiaper Rash, Diaper DermatitisArmsOxygen
NCT05945017 naactive not recruitingnot on this map

Probiotics and the Neurodevelopment in the Premature Infant <32 Weeks Gestational Age and <1500g

TypeinterventionalSponsorFundacion Clinic per a la Recerca BiomédicaRan2014 to 2027Enrolled233ConditionsInfant, Newborn, Diseases, Infant DevelopmentArmsInfloran® -Berne, Switzerland- (Bifidobacterium bifidum NCDO 2203 and Lactobacillus acidophilus NCDO 1748
3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Shaping Microbiota During the First 1000 Days of Life.Advances in experimental medicine and biology · 2024
    Review
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mark A UnderwoodDepartment of Pediatrics, University of California Davis, 2516 Stockton Boulevard, Sacramento, CA 95817, USA. Electronic address: munderwood@ucdavis.edu.
Kristin SohnDepartment of Pediatrics, University of California Davis, 2516 Stockton Boulevard, Sacramento, CA 95817, USA.

Funding

Necrotizing Enterocolitis: Prevention and PredictionR01HD059127 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEBRILLA, CARLITO B, MILLS, DAVID ANDREW · 2008 to 2012
$3.1M
NICHD NIH HHS R01 HD059127
6 · The paper itself

Abstract

Colonization of the extremely preterm infant's gastrointestinal tract and skin begins in utero and is influenced by a variety of factors, the most important including gestational age and environmental exposures. The composition of the intestinal and skin microbiota influences the developing innate and adaptive immune responses with short-term and long-term consequences including altered risks for developing necrotizing enterocolitis, sepsis, and a wide variety of microbe-related diseases of children and adults. Alteration of the composition of the microbiota to decrease disease risk is particularly appealing for this ultra-high-risk cohort that is brand new from an evolutionary standpoint.

Indexed as

Gastrointestinal MicrobiomeAnti-Bacterial AgentsDysbiosisEnterocolitis, NecrotizingHumansInfant, Extremely PrematureInfant, NewbornMicrobiotaMouthNeonatal SepsisPrebioticsProbioticsSkinAnti-Bacterial AgentsPrebioticsDysbiosisIntestinal tractLate-onset sepsisMicrobiotaNecrotizing enterocolitisOral cavitySkin

Identifiers

PMID28477669
PMCPMC6361543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.